HUP9901935A3 - Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) - Google Patents
Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)Info
- Publication number
- HUP9901935A3 HUP9901935A3 HU9901935A HUP9901935A HUP9901935A3 HU P9901935 A3 HUP9901935 A3 HU P9901935A3 HU 9901935 A HU9901935 A HU 9901935A HU P9901935 A HUP9901935 A HU P9901935A HU P9901935 A3 HUP9901935 A3 HU P9901935A3
- Authority
- HU
- Hungary
- Prior art keywords
- gags
- glycosaminoglycans
- dosages
- targeting
- medicine
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- 229920002683 Glycosaminoglycan Polymers 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002164260A CA2164260C (en) | 1995-12-01 | 1995-12-01 | Targeting of dosages of medicines and therapeutic agents |
CA 2173037 CA2173037A1 (en) | 1996-03-29 | 1996-03-29 | Targeting of dosages of medicines and therapeutic agents and other glycosaminoglycans (gags) |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9901935A2 HUP9901935A2 (en) | 1999-11-29 |
HUP9901935A3 true HUP9901935A3 (en) | 2001-04-28 |
Family
ID=25678243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901935A HUP9901935A3 (en) | 1995-12-01 | 1996-11-29 | Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0869798A1 (en) |
JP (1) | JP2000513707A (en) |
KR (1) | KR19990071628A (en) |
AU (1) | AU727001B2 (en) |
BR (1) | BR9611671A (en) |
HU (1) | HUP9901935A3 (en) |
IL (1) | IL124647A0 (en) |
MX (1) | MX9804343A (en) |
NO (1) | NO982441L (en) |
PL (1) | PL326970A1 (en) |
WO (1) | WO1997020564A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITPD940054A1 (en) * | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | SULPHATED POLYSACCHARIDES |
ES2295005T3 (en) | 1999-01-13 | 2008-04-16 | Alchemia Oncology Pty Limited | USE OF HIALURONANE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE IMPROVEMENT OF THE EFFECTIVENESS OF CITOTOXIC PHARMACOS. |
AUPQ879500A0 (en) | 2000-07-14 | 2000-08-10 | Meditech Research Limited | Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease |
US9066919B2 (en) | 2000-07-14 | 2015-06-30 | Alchemia Oncology Pty Limited | Hyaluronan as a chemo-sensitizer in the treatment of cancer |
EP1912658B1 (en) | 2005-07-27 | 2017-01-25 | Alchemia Oncology Pty Limited | Therapeutic protocols using hyaluronan |
AU2006289651B2 (en) | 2005-09-07 | 2012-07-26 | Alchemia Oncology Pty Limited | Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
WO1996006622A1 (en) * | 1991-07-03 | 1996-03-07 | Hyal Pharmaceutical Corporation | Hyaluronic acid and derivatives for modulation of cellular activity |
AUPM714794A0 (en) * | 1994-07-29 | 1994-08-18 | International Fluid Separation Pty Limited | Separation apparatus and method |
-
1996
- 1996-11-29 JP JP09520818A patent/JP2000513707A/en not_active Ceased
- 1996-11-29 HU HU9901935A patent/HUP9901935A3/en unknown
- 1996-11-29 IL IL12474796A patent/IL124647A0/en not_active IP Right Cessation
- 1996-11-29 EP EP96939774A patent/EP0869798A1/en not_active Ceased
- 1996-11-29 KR KR1019980703904A patent/KR19990071628A/en not_active Application Discontinuation
- 1996-11-29 WO PCT/CA1996/000793 patent/WO1997020564A1/en not_active Application Discontinuation
- 1996-11-29 PL PL96326970A patent/PL326970A1/en unknown
- 1996-11-29 AU AU76878/96A patent/AU727001B2/en not_active Ceased
- 1996-11-29 BR BR9611671-4A patent/BR9611671A/en not_active Application Discontinuation
-
1998
- 1998-05-28 NO NO982441A patent/NO982441L/en unknown
- 1998-06-01 MX MX9804343A patent/MX9804343A/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR19990071628A (en) | 1999-09-27 |
NO982441D0 (en) | 1998-05-28 |
AU7687896A (en) | 1997-06-27 |
PL326970A1 (en) | 1998-11-09 |
MX9804343A (en) | 1998-09-30 |
HUP9901935A2 (en) | 1999-11-29 |
BR9611671A (en) | 1999-12-28 |
EP0869798A1 (en) | 1998-10-14 |
IL124647A0 (en) | 1998-12-06 |
JP2000513707A (en) | 2000-10-17 |
NO982441L (en) | 1998-05-28 |
WO1997020564A1 (en) | 1997-06-12 |
AU727001B2 (en) | 2000-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP960300B1 (en) | Inhaler for administration of blister-packed medicaments | |
EP0745401A3 (en) | Inhaler type medicine administering device | |
EP0692975A4 (en) | Administration of vaso-active agent and therapeutic agent | |
EP0759306A3 (en) | Medicine administering apparatus | |
WO1994027589A3 (en) | Antidepressant dosage form | |
IL117237A (en) | Pharmaceutical compositions of piperidinoalkanol compounds in solid unit dosage form | |
PL326149A1 (en) | Pharmaceutic dipeptides containing angiostatic agents and methods of their application | |
HUP9900751A3 (en) | Stable pharmaceutical forms of administration containing parathormone | |
AU9018898A (en) | Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments | |
HU9602671D0 (en) | Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction | |
IL116993A0 (en) | Extended-release solid oral dosage forms of drugs having low solubility in water | |
HUP9900186A3 (en) | Use of lamellarin alkaloids in therapy and pharmaceutical compositions containing them | |
EP0817655A4 (en) | Intrapulmonary delivery of hematopoietic drug | |
IL125913A0 (en) | Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases | |
CA2120062A1 (en) | Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy | |
HUP9900147A2 (en) | Therapeutic agents and pharmaceutical compositions for treatment of autoimmune diseases | |
IL119459A0 (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases | |
HUP9901935A3 (en) | Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) | |
ZA967915B (en) | Therapeutic administration of hemoglobin in cardiac arrest | |
ZA9610039B (en) | Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) | |
ZA95908B (en) | A synergistic formulation for treatment of rheumatic diseases | |
GB9524942D0 (en) | Drug therapy | |
HUP0004647A3 (en) | Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye | |
GB9415873D0 (en) | Compounds that are inhibitors of acyl enzyme-a-cholesterol-o-acyl-transferase and have therapeutic activity, their use and pharmaceutical compositions contain | |
GB9507677D0 (en) | Pharmaceutical formulation and dose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |